Cargando…
Identification of the antigen recognized by rHIgM22, a remyelination-promoting human monoclonal antibody
Autores principales: | Grassi, Sara, Prioni, Simona, Zorina, Yana, Cabitta, Livia, Sonnino, Sandro, Prinetti, Alessandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4797495/ http://dx.doi.org/10.1186/2193-1801-4-S1-P15 |
Ejemplares similares
-
Human IgM antibody rHIgM22 promotes phagocytic clearance of myelin debris by microglia
por: Zorina, Yana, et al.
Publicado: (2018) -
Sphingosine 1-Phosphate Receptors and Metabolic Enzymes as Druggable Targets for Brain Diseases
por: Grassi, Sara, et al.
Publicado: (2019) -
A double-blind, placebo-controlled, single ascending-dose study of remyelinating antibody rHIgM22 in people with multiple sclerosis
por: Eisen, Andrew, et al.
Publicado: (2017) -
A double-blind, placebo-controlled, single-ascending-dose intravenous infusion study of rHIgM22 in subjects with multiple sclerosis immediately following a relapse
por: Greenberg, Benjamin M., et al.
Publicado: (2022) -
Glycohydrolases in the central nervous system: the role of GBA2 in the neuronal differentiation
por: Samarani, Maura, et al.
Publicado: (2015)